Drug Trial Radar · NCT05764642
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
186
Planned (sponsor's estimate)
Start
Aug 9, 2023
Primary completion
Apr 1, 2028
Study completion Apr 2028
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Mar 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.
Conditions
- Healthy
- Chronic Kidney Diseases
Interventions
DefinityDrug
Ultrasound contrast agent administered intravenously
Super-resolution ultrasound imagingDiagnostic test
Imaging technology for microvessel imaging. This technology localizes and tracks individual microbubbles (FDA approved ultrasound contrast agents) to map microvessel morphology and flow speed at a spatial resolution about 10 times higher than conventional ultrasound imaging.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Renal cortex microvessel densityTime frame: Baseline
- Renal cortex microvessel diameterTime frame: Baseline
- Renal blood flow velocityTime frame: Baseline
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Florida
Jacksonville, Florida
Mayo Clinic Minnesota
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.